Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial)
VPM1002 和 Immuvac 预防结核病的有效性和安全性:3 期随机临床试验(PreVenTB 试验)
期刊:Bmj-British Medical Journal
影响因子:42.7
doi:10.1136/bmj-2025-085716
Singh, Manjula; Joshi, Sindhu; Vohra, Vikram; Sarin, Rohit; Kamble, Suchit Vasant; Velayutham, Banurekha; Mohan, Anant; Singh, Urvashi B; Kumar, Rakesh; Pati, Sanghamitra; Pattnaik, Manoranjan; Mohapatra, Prasanta Raghab; Shankar, Uma; Narasimhaiah, Somashekar; Yadav, Geeta; Hissar, Syed; Rodrigues, Rashmi; Kadam, Abhijit Vasantrao; Paramasivam, Paul Kumaran; Kambhampati, Sailaja; Newtonraj, Ariarathinam; Palaniappan, Natarajan Alangudi; Reddy, S Devarajulu; Bhuniya, Sourin; Mishra, Bijaya Kumar; Shete, Ashwini; Hanna, Luke Elizabeth; Mitra, Dipendra Kumar; Panda, Samiran; Guleria, Randeep; Tripathy, Srikanth; Roy, Neelam; D'Souza, George; Tripathy, S K; Katoch, Kiran; Pandey, Ravindra M; Sah, Seema; Kashyap, Manisha; Telasey, Vinay; Bakshi, Meenakshi; Wadhwa, Nitya; Khan, Abdul Mabood; Gangakhedkar, Raman R; Rani, Rajni